Stem Cells, FDA, and the Edge of Science: Three Expert Viewpoints

Last week I wrote about a pending lawsuit by the FDA against Regenerative Sciences, a medical company that developed a stem cell treatment for orthopedic injuries.  While adult stem cell therapies have been fraught with concerns about safety and efficacy, this case is particularly important not only because it is unprecedented — the FDA is (Source: Forbes.com Healthcare News)